MS and Oxygen Therapy: What the Research Quietly Suggests

Walk into almost any conversation about multiple sclerosis and alternative therapies, and hyperbaric oxygen therapy (HBOT) will come up sooner or later. In the UK, a network of MS therapy centres has offered it to members for decades. Online, you’ll find passionate testimonials. And in the medical literature, you’ll find something more complicated – and more honest – than either the enthusiasts or the sceptics tend to admit.

Here’s a clear-eyed look at where HBOT and MS actually stand.

The theory behind it

Multiple sclerosis is a chronic condition in which the immune system damages the protective myelin around nerves, disrupting the signals between brain and body. The original rationale for HBOT was that flooding tissues with oxygen might reduce inflammation, support damaged nerve tissue, and slow the disease.

HBOT does deliver oxygen in a way ordinary breathing can’t: under pressure, far more oxygen dissolves into the blood plasma and reaches tissues that may be poorly perfused. If the mechanism is new to you, our overview of HBOT explains how that works and which conditions have stronger versus weaker evidence behind them.

What the evidence actually shows

This is where honesty matters. A Cochrane systematic review – the most rigorous way to weigh medical evidence – examined nine randomised trials involving more than 500 participants and found no consistent evidence that HBOT modifies the progression of MS or reliably improves disability overall. 

So why hasn’t HBOT disappeared from the MS conversation? Because the picture isn’t entirely blank. Some trials reported modest improvements in specific symptoms – most notably bladder function, with fatigue and spasticity sometimes mentioned – and many patients in the long-running MS therapy centre network report subjective benefits in energy and clarity. These are not the same as disease modification, and the controlled evidence for them is inconsistent, but they’re the reason real-world use has persisted.

The fair summary: HBOT does not appear to slow or reverse MS, but a subset of people report symptomatic relief that controlled trials haven’t been able to confirm reliably. It is not an approved MS treatment, and disease-modifying therapies prescribed by a neurologist remain the cornerstone of care.

Symptom support versus disease modification

This distinction is the most important thing to take away. If someone hopes HBOT will halt their MS, the evidence simply doesn’t support that expectation. If someone is exploring it as a complementary, wellness-focused way to support energy, sleep, or general wellbeing while continuing their prescribed treatment, that’s a more realistic framing – and one worth discussing candidly with their care team.

Because oxygen plays a role in tissue repair and inflammation, the symptoms people most often mention – fatigue and cognitive fog – overlap with areas where HBOT is being explored across other conditions. Our look at HBOT and brain-related recovery in anoxic brain injury covers the neurological mechanisms in more depth, and our top benefits overview explains the general wellness rationale.

Practical and safety notes

MS-specific protocols in the older trials typically used pressures around 1.75–2.0 ATA. For general wellness use at home, mild chambers (1.3–1.5 ATA) are gentler and designed for recovery support rather than medical treatment. Either way, anyone with MS should involve their neurologist before starting – partly to set realistic expectations, and partly because individual circumstances vary.

The honest bottom line: HBOT is not a breakthrough MS treatment, and the strongest evidence says it won’t change the disease’s course. But for a chronic, unpredictable condition, some people value it as a complementary tool for symptom support – provided it’s pursued with clear expectations and alongside, never instead of, proper medical care.

Frequently Asked Questions

Does hyperbaric oxygen therapy slow down MS?

The most rigorous evidence – a Cochrane review of nine trials – found no consistent evidence that HBOT modifies MS progression or reliably reduces disability. It is not an approved treatment for MS.

Why do some MS patients still use HBOT?

Some trials and many patient reports describe modest improvements in specific symptoms, particularly bladder function, and sometimes fatigue or spasticity. These are symptomatic effects, not disease modification, and the controlled evidence is inconsistent.

Can HBOT replace my prescribed MS medication?

No. Disease-modifying therapies remain the cornerstone of MS care. HBOT should only ever be considered a complementary, wellness-focused option used alongside treatment prescribed by your neurologist.

What pressure is used for MS?

Older MS trials generally used around 1.75–2.0 ATA. Mild home chambers operate at 1.3–1.5 ATA and are intended for wellness and recovery support rather than clinical treatment.

Is HBOT safe for people with MS?

HBOT is generally well tolerated, with mild ear or sinus pressure being the most common effect. Because individual MS circumstances vary, always consult your neurologist before starting.

This article is for informational purposes only. Hyperbaric oxygen products are intended for wellness use and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any new therapy.